Sernova Corp. (CVE:SVA) shares traded up 11.4% during trading on Monday . The company traded as high as C$0.20 and last traded at C$0.20, 247,000 shares were traded during trading. An increase of 0% from the average session volume of 246,052 shares. The stock had previously closed at C$0.18.
Separately, Echelon Wealth Partners reaffirmed a “speculative buy” rating on shares of Sernova in a research report on Wednesday, May 1st.
The stock’s 50-day moving average is C$0.22. The firm has a market capitalization of $39.62 million and a price-to-earnings ratio of -8.81.
Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch and associated technologies, including therapeutic cells and local immune protection. The company is developing a Cell Pouch system that is in Phase I/II clinical trial for the treatment of type-1 diabetes.
Featured Story: What are economic reports?
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.